Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care

被引:0
|
作者
Tack, J. [1 ]
Louis, E. [2 ,3 ]
Persy, V. [4 ]
Urbain, D. [5 ]
机构
[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, B-3000 Louvain, Belgium
[2] CHU, Liege, Belgium
[3] Univ Liege, Liege, Belgium
[4] Hugin Mugin Res, Antwerp, Belgium
[5] Vrije Univ Brussel, UZ Brussel, Dept Gastroenterol, Brussels, Belgium
关键词
Proton pump inhibitors; acid peptic diseases; best practices; review; GASTROESOPHAGEAL-REFLUX DISEASE; FUNCTIONAL DYSPEPSIA; HELICOBACTER-PYLORI; CLINICAL-TRIALS; ESOPHAGEAL PH; PPI THERAPY; LIFE-STYLE; SYMPTOMATIC PATIENTS; GENERAL-POPULATION; DOUBLE-BLIND;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Heartburn, reflux and epigastric pain are frequently encountered symptoms in primary care medicine. Acid peptic diseases such as peptic ulcer and gastrointestinal reflux disease have a high prevalence, can have important impact on patient quality of life and represent a considerable health care cost. Proton pump inhibitors (PPIs) are the most potent pharmacological inhibitors of gastric acid secretion currently available and are the mainstay medical therapy for acid peptic diseases. This review summarizes current evidence on treatment of acid-peptic diseases with proton pump inhibitors and provides primary care clinicians with best practice guidelines for optimal use of these drugs.
引用
收藏
页码:393 / 402
页数:10
相关论文
共 50 条
  • [31] Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population
    Chan, J
    Hui, RL
    Szpakowski, JL
    AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (07): : 433 - 441
  • [32] The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage
    James M Scheiman
    Arthritis Research & Therapy, 15
  • [33] The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage
    Scheiman, James M.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15
  • [34] Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases
    Robinson, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (06) : 709 - 715
  • [35] Optimal Inpatient Dosing of Proton Pump Inhibitors
    DiJoseph, Kara
    Roy, Justin
    Sahu, Nitasa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1422 - S1422
  • [36] The use and abuse of proton pump inhibitors
    Raqunath, K
    Praveen, E
    Dew, MJ
    GUT, 1999, 44 : A3 - A3
  • [37] Use and overuse of proton pump inhibitors
    Annamaria Staiano
    Paolo Quitadamo
    Italian Journal of Pediatrics, 41 (Suppl 2)
  • [38] Inappropriate use of proton pump inhibitors
    Molloy, D.
    Molloy, A.
    O'Loughlin, C.
    Falconer, M.
    Hennessy, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 (01) : 73 - 75
  • [39] Inappropriate use of proton pump inhibitors
    D. Molloy
    A. Molloy
    C. O’Loughlin
    M. Falconer
    M. Hennessy
    Irish Journal of Medical Science, 2010, 179 : 73 - 75
  • [40] Use and abuse of proton pump inhibitors
    Grigg, Erika
    Balart, J. Carter
    Williams, Dianne B.
    Schade, Robert R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S450 - S450